Requisitos y sostenibilidad de los programas de ICP primaria en España en el IAMCEST.Documento de consenso de SEC, AEEC y SEMES

  1. Angel Cequier 1
  2. Armando Pérez de Prado 2
  3. B. Cid Álvarez 3
  4. Javier Martín Moreiras 4
  5. Oriol Rodríguez-Leor 5
  6. José R. Rumoroso Cuevas 6
  7. Raúl Moreno Gómez 7
  8. Ana María Serrador Frutos 8
  9. Sergio Raposeiras Roubín 9
  10. Albert Ariza Solé 1
  11. Esteban López de Sá 7
  12. A. Íñiguez Romo 9
  13. José Luis López-Sendón Hentschel 7
  14. Francisco Javier Delgado 10
  15. Rocío Gil Pérez 11
  16. José Julio Jiménez Alegre 12
  17. Manuel José Vázquez Lima 13
  18. José Manuel Flores 14
  19. Héctor Bueno 15
  20. Manuel Anguita Sánchez 16
  1. 1 Área de Enfermedades del Corazón, Hospital Universitario de Bellvitge, IDIBELL, Universidad de Barcelona, L’Hospitalet de Llobregat, Barcelona, España
  2. 2 Servicio de Cardiología, Hospital Universitario de León, León, España
  3. 3 Servicio de Cardiología, Hospital Clínico Universitario de Santiago, Santiago de Compostela, A Coruña, España
  4. 4 Servicio de Cardiología, Hospital Universitario de Salamanca, Salamanca, España
  5. 5 Servicio de Cardiología, Hospital Germans Trias i Pujol, Badalona, Barcelona, España
  6. 6 Servicio de Cardiología, Hospital Galdakao-Usansolo, Galdakao, Vizcaya, España
  7. 7 Servicio de Cardiología, Hospital Universitario La Paz, IDIPAZ, Madrid, España
  8. 8 Servicio de Cardiología, Hospital Clínico Universitario de Valladolid, Valladolid, España
  9. 9 Servicio de Cardiología, Hospital Álvaro Cunqueiro, Vigo, Pontevedra, España
  10. 10 Servicio de Cardiología, Hospital de la Santa Creu i Sant Pau, Barcelona, España
  11. 11 Servicio de Cardiología, Hospital Universitario Virgen de la Victoria, Málaga, España
  12. 12 SUMMA 112, Madrid, Universidad Alfonso X el Sabio, Villanueva de la Cañada, Madrid, España
  13. 13 Servicio de Cardiología, Hospital do Salnés, Vilagarcía de Arousa, Pontevedra, España
  14. 14 Urgencias Sanitarias de Galicia 061, Santiago de Compostela, A Coruña, España
  15. 15 Servicio de Cardiología, Hospital Universitario 12 de Octubre, Madrid, España
  16. 16 Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, España
Mostrar afiliaciones +
Revista:
REC: Interventional Cardiology

ISSN: 2604-7276,  2604-7306

Año de publicación: 2019

Volumen: 1

Número: 2

Páginas: 108-119

Tipo: Artículo

DOI: 10.24875/RECIC.M19000037 SCOPUS: 2-s2.0-85073830905 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

Otras publicaciones en: REC: Interventional Cardiology

Resumen

El intervencionismo coronario percutáneo primario (ICPp) es la mejor forma de reperfusión en el infarto agudo de miocardio con elevación del segmento ST (IAMCEST). Su aplicación requiere sistemas asistenciales en red cuya implementación exige cambios organizativos y logísticos importantes. En comparación con otros escenarios de actuación urgente, una serie de aspectos son específicos de los programas de ICPp. Requieren de estrategias inmediatas claramente preestablecidas, realizadas por profesionales muy expertos y que atienden a un elevado volumen de pacientes de alta complejidad. La falta de homogeneidad en la creación y desarrollo de los programas de reperfusión en España ha llevado a grandes diferencias en su implantación. Si los programas de ICPp no se efectúan en condiciones adecuadas su sostenibilidad puede ser compleja. El presente documento, consensuado entre diferentes sociedades científicas, tiene por objetivos analizar la situación actual en España de los programas de atención en red al IAMCEST, identificar sus limitaciones y deficiencias, evaluar su vulnerabilidad y establecer una serie de recomendaciones para asegurar su sostenibilidad.

Referencias bibliográficas

  • 1. Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe:epidemiological update 2016. Eur Heart J. 2016;37:3232-3245.
  • 2. Grines CL. Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction?Primary angioplasty —the strategy of choice. N Engl J Med. 1996;335:1313-1316.
  • 3. GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 1993;329:1615-1622.
  • 4. GUSTO Angiographic Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673-682.
  • 5. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction:quantitative review of randomised trials. Lancet. 2006;367:579-588.
  • 6. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119-177.
  • 7. Aasa M, Henriksson M, Dellborg M, et al. Cost and health outcome of primary percutaneous coronary intervention versus thrombolysis in acute ST-segment elevation myocardial infarction —Results of the Swedish Early Decision reperfusion Study (SWEDES) trial. Am Heart J. 2010;160:322-328.
  • 8. Wailoo A, Goodacre S, Sampson F, et al. Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction:an economic analysis of the National Infarct Angioplasty project. Heart. 2010;96:668-672.
  • 9. Stone GW, Grines CL, Rothbaum D, et al. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator:the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators. J Am Coll Cardiol. 1997;29:901-907.
  • 10. Cequier A, Ariza-Sole A, Elola FJ, et al. Impact on Mortality of Different Network Systems in the Treatment of ST-segment Elevation Acute Myo-cardial Infarction. The Spanish Experience. Rev Esp Cardiol. 2017;70:155-161.
  • 11. Alter DA, Austin PC, Tu JV, Canadian Cardiovascular Outcomes Research T. Community factors, hospital characteristics and inter-regional outcome variations following acute myocardial infarction in Canada. Can J Cardiol. 2005;21:247-255.
  • 12. Bertomeu V, Cequier A, Bernal JL, et al. In-hospital mortality due to acute myocardial infarction. Relevance of type of hospital and care provided. RECALCAR study. Rev Esp Cardiol. 2013;66:935-942.
  • 13. Laskey W, Spence N, Zhao X, et al. Regional differences in quality of care and outcomes for the treatment of acute coronary syndromes:an analysis from the get with the guidelines coronary artery disease program. Crit Pathw Cardiol. 2010;9:1-7.
  • 14. Carrillo P, Lopez-Palop R, Pinar E, et al. Program of Coronary Angioplasty in Acute Myocardial Infarction in the Region of Murcia (Spain): APRIMUR Registry. Rev Esp Cardiol. 2002;55:587-596.
  • 15. Widimsky P, Wijns W, Fajadet J, et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe:description of the current situation in 30 countries. Eur Heart J. 2010;31:943-957.
  • 16. Feldman MF, Goicolea J, Macaya C. The Aims of the Stent-for-Life Initiative in Spain in 2010-2013. Rev Esp Cardiol. 2011;11(Supl):6-8.
  • 17. Cid Álvarez AB, Rodríguez Leor O, Moreno R, Pérez de Prado A. Spanish Cardiac Catheterization and Coronary Intervention Registry. 27th Official Report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2017).Rev Esp Cardiol. 2018;71:1036-1046.
  • 18. Kristensen SD, Laut KG, Fajadet J, et al. Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011:current status in 37 ESC countries. Eur Heart J. 2014;35:1957-1970.
  • 19. Schiele F, Hochadel M, Tubaro M, et al. Reperfusion strategy in Europe:temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction. Eur Heart J. 2010;31:2614-2624.
  • 20. Gómez-Hospital JA, Dallaglio PD, Sanchez-Salado JC, et al. Impact on delay times and characteristics of patients undergoing primary percutaneous coronary intervention in the southern metropolitan area of Barcelona after implementation of the infarction code program. Rev Esp Cardiol. 2012;65:911-918.
  • 21. Rodríguez-Padial L, Bertomeu V, Elola FJ, et al. Quality Improvement Strategy of the Spanish Society of Cardiology:The RECALCAR Registry. J Am Coll Cardiol. 2016;68:1140-1142.
  • 22. Lambert L, Brown K, Segal E, Brophy J, Rodes-Cabau J, Bogaty P. Association between timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction. JAMA. 2010;303:2148-2155.
  • 23. Tarantini G, Razzolini R, Napodano M, Bilato C, Ramondo A, Iliceto S. Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk:1 h does not fit all. Eur Heart J. 2010;31:676-683.
  • 24. Cequier A, Maristany J. Angioplàstia primària. Estrategies per a la seva aplicacióa diferents àmbits sanitaris. Rev Soc Catalana Cardiol. 2005;5:290-297.
  • 25. Cantor WJ, Fitchett D, Borgundvaag B, et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med. 2009;360:2705-2718.
  • 26. Sinnaeve PR, Armstrong PW, Gershlick AH, et al. ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention:Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up. Circulation. 2014;130:1139-1145.
  • 27. López-Sendón J, González-Juanatey JR, Pinto F, et al. Quality Markers in Cardiology. Main Markers to Measure Quality of Results (Outcomes) and Quality Measures Related to Better Results in Clinical Practice (Performance Metrics). INCARDIO (Indicadores de Calidad en Unidades Asistenciales del Area del Corazon):A SEC/SECTCV Consensus Position Paper. Rev Esp Cardiol. 2015;68:976-995.
  • 28. Bonnefoy-Cudraz E, Bueno H, Casella G, et al. Editor's Choice —Acute Cardiovascular Care Association Position Paper on Intensive Cardiovascular Care Units:An update on their definition, structure, organisation and function. Eur Heart J Acute Cardiovasc Care. 2018;7:80-95.
  • 29. Palanca I, Elola FJ, Bernal JL, Paniagua JL. Unidad de cuidados intensivos. Estándares y recomendaciones. Agencia de Calidad del SNS. Madrid:Mi-nisterio de Sanidad y Política Social;2009.
  • 30. Dehmer GJ, Blankenship JC, Cilingiroglu M, et al. SCAI/ACC/AHA Expert Consensus Document:2014 update on percutaneous coronary intervention without on-site surgical backup. J Am Coll Cardiol. 2014;63:2624-2641.
  • 31. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574-651.
  • 32. Tubaro M, Danchin N, Goldstein P, et al. Pre-hospital treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac Care of the European Society of Cardiology. Rev Esp Cardiol. 2012;65:60-70.
  • 33. Nuñez Gil IJ, Fernández-Ortiz A, Escaned J, et al. Long term experience with a novel interventional cardiology network model:Learned lessons. J Hos Administ. 2016;5:87-94.
  • 34. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40:87-165.
  • 35. Dharma S, Dakota I, Sukmawan R, Andriantoro H, Siswanto BB, Rao SV. Two-year mortality of primary angioplasty for acute myocardial infarction during regular working hours versus off-hours. Cardiovasc Revasc Med. 2018;19:826-830.
  • 36. Graham MM, Ghali WA, Southern DA, Traboulsi M, Knudtson ML;APPROACH Investigators. Outcomes of after-hours versus regular working hours primary percutaneous coronary intervention for acute myocardial infarction. BMJ Qual Saf. 2011;20:60-67.
  • 37. Siudak Z, Rakowski T, Dziewierz A, et al. Primary percutaneous coronary intervention during on- vs off-hours in patients with ST-elevation myocardial infarction. Results from EUROTRANSFER Registry. Kardiol Pol. 2011;69:1017-1022.
  • 38. Sandoval Y, Lobo AS, Somers VK, et al. Sleep deprivation in interventional cardiology:Implications for patient care and physician-health. Catheter Cardiovasc Interv. 2018;91:905-910.
  • 39. Klein LW, Miller DL, Balter S, et al. Occupational health hazards in the interventional laboratory:Time for a safer environment. Catheter Cardiovasc Interv. 2009;73:432-438.
  • 40. Roguin A, Goldstein J, Bar O, Goldstein JA. Brain and neck tumors among physicians performing interventional procedures. Am J Cardiol. 2013;111:1368-1372.
Fuente de los datos: Dialnet